268 related articles for article (PubMed ID: 19013186)
1. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues revisited.
Morris DJ; Latif SA; Brem AS
Steroids; 2009 Jan; 74(1):1-6. PubMed ID: 19013186
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: receptor transactivation and prereceptor metabolism by 11beta-hydroxysteroid-dehydrogenases.
Diederich S; Scholz T; Eigendorff E; Bumke-Vogt Ch; Quinkler M; Exner P; Pfeiffer AF; Oelkers W; Bähr V
Horm Metab Res; 2004 Jun; 36(6):423-9. PubMed ID: 15241735
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone enhances basal and TNF-alpha-stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11beta-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells.
Kimura H; Li X; Torii K; Okada T; Kamiyama K; Mikami D; Takahashi N; Yoshida H
Nephrol Dial Transplant; 2009 Jun; 24(6):1759-65. PubMed ID: 19153071
[TBL] [Abstract][Full Text] [Related]
4. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues.
Morris DJ; Souness GW; Brem AS; Oblin ME
Kidney Int; 2000 Apr; 57(4):1370-3. PubMed ID: 10760069
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line.
Gaeggeler HP; Gonzalez-Rodriguez E; Jaeger NF; Loffing-Cueni D; Norregaard R; Loffing J; Horisberger JD; Rossier BC
J Am Soc Nephrol; 2005 Apr; 16(4):878-91. PubMed ID: 15743993
[TBL] [Abstract][Full Text] [Related]
6. In vivo nuclear translocation of mineralocorticoid and glucocorticoid receptors in rat kidney: differential effect of corticosteroids along the distal tubule.
Ackermann D; Gresko N; Carrel M; Loffing-Cueni D; Habermehl D; Gomez-Sanchez C; Rossier BC; Loffing J
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1473-85. PubMed ID: 20861076
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone enhances 11beta-hydroxysteroid dehydrogenase type 2 expression in colonic epithelial cells in vivo.
Fukushima K; Funayama Y; Yonezawa H; Takahashi K; Haneda S; Suzuki T; Sasano H; Naito H; Shibata C; Krozowski ZS; Sasaki I
Scand J Gastroenterol; 2005 Jul; 40(7):850-7. PubMed ID: 16109662
[TBL] [Abstract][Full Text] [Related]
9. Impairment of the antiproliferative effect of glucocorticosteroids by 11beta-hydroxysteroid dehydrogenase type 2 overexpression in MCF-7 breast-cancer cells.
Lipka C; Mankertz J; Fromm M; Lübbert H; Bühler H; Kühn W; Ragosch V; Hundertmark S
Horm Metab Res; 2004 Jul; 36(7):437-44. PubMed ID: 15305225
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptors: emerging complexity and functional diversity.
Odermatt A; Atanasov AG
Steroids; 2009 Feb; 74(2):163-71. PubMed ID: 19022273
[TBL] [Abstract][Full Text] [Related]
11. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.
Diederich S; Eigendorff E; Burkhardt P; Quinkler M; Bumke-Vogt C; Rochel M; Seidelmann D; Esperling P; Oelkers W; Bähr V
J Clin Endocrinol Metab; 2002 Dec; 87(12):5695-701. PubMed ID: 12466373
[TBL] [Abstract][Full Text] [Related]
12. 11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites.
Garbrecht MR; Schmidt TJ; Krozowski ZS; Snyder JM
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E653-60. PubMed ID: 16263772
[TBL] [Abstract][Full Text] [Related]
13. Cortisol resistance in conditions such as asthma and the involvement of 11beta-HSD-2: a hypothesis.
Pretorius E; Wallner B; Marx J
Horm Metab Res; 2006 Jun; 38(6):368-76. PubMed ID: 16823718
[TBL] [Abstract][Full Text] [Related]
14. Adrenal gland involvement in the regulation of renal 11beta-hydroxysteroid dehydrogenase 2.
Zallocchi ML; Matkovic L; Calvo JC; Damasco MC
J Cell Biochem; 2004 Jun; 92(3):591-602. PubMed ID: 15156570
[TBL] [Abstract][Full Text] [Related]
15. Human renal 11beta-hydroxysteroid dehydrogenase 1 functions and co-localizes with COX-2.
Gong R; Morris DJ; Brem AS
Life Sci; 2008 Mar; 82(11-12):631-7. PubMed ID: 18261751
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptors: distribution and activation.
Funder JW
Heart Fail Rev; 2005 Jan; 10(1):15-22. PubMed ID: 15947887
[TBL] [Abstract][Full Text] [Related]
17. Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats.
Bistrup C; Thiesson HC; Jensen BL; Skøtt O
Acta Physiol Scand; 2005 Jun; 184(2):161-9. PubMed ID: 15916676
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenase 2 in human gastric mucosa.
Kato K; Sasano H; Ohara S; Sekine H; Mochizuki S; Mune T; Yasuda K; Nagura H; Shimosegawa T; Toyota T; Krozowski Z
J Clin Endocrinol Metab; 1999 Jul; 84(7):2568-73. PubMed ID: 10404838
[TBL] [Abstract][Full Text] [Related]
19. Arginine vasopressin stimulates 11beta-hydroxysteroid dehydrogenase type 2 expression in the mineralocorticosteroid target cells.
Rubis B; Krozowski Z; Trzeciak WH
Mol Cell Endocrinol; 2006 Aug; 256(1-2):17-22. PubMed ID: 16872738
[TBL] [Abstract][Full Text] [Related]
20. Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat.
Tang JI; Kenyon CJ; Seckl JR; Nyirenda MJ
J Hypertens; 2011 Feb; 29(2):282-9. PubMed ID: 21045727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
